

By Jenna Sundel and Gabe Whisnant
0
Share
Newsweek is a Trust Project member
See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.
Kratom‑derived 7‑hydroxymitragynine (7‑OH) is at the center of a sweeping Food and Drug Administration crackdown announced on Tuesday. The FDA sent seven formal warning letters to companies illegally marketing concentrated 7‑OH products such as gummies, tablets, and drink mixes often sold in gas stations, smoke shops and online.
Why It Matters
The FDA emphasized that 7‑OH is a potent, unapproved opioid-like compound not permitted in dietary supplements or conventional foods. Officials also called for federal scheduling of the substance due to its risks, distinguishing it from the natural kratom plant.
Read More on U.S.
The availability of 7-OH products is a "major concern" to the FDA, the agency said in a news release.

...
What To Know
The FDA said the recommendation follows medical and scientific analysis by the agency, which is particularly concerned about a growing market of 7-OH products that may appeal to juveniles, including gummies and ice cream cones.
"These products may not be clearly or accurately labeled to their 7-OH content and are sometimes disguised or marketed as kratom," the FDA said.
The agency said it has sent warning letters to seven companies for allegedly illegally distributing 7-OH products. The agency also issued a letter to health care professionals about the risks associated with these products.
What Is 7-OH?
7-OH is a psychoactive compound that occurs naturally in small amounts in the kratom plant.
The FDA said the substance can cause respiratory depression, physical dependence and withdrawal symptoms similar to common opioids, like morphine, fentanyl, oxycodone and hydrocodone.

...
What Is Kratom?
Kratom refers to Mitragyna speciosa, a tree native to Southeast Asia, and products derived from its leaves marketed as herbal supplements, according to the National Institute on Drug Abuse. The most well-studied compounds related to kratom are mitragynine and 7-OH, according to the institute.
The FDA has not approved Kratom and its related products for any medical use. Some people have reported using kratom products for pain, anxiety and drug withdrawal symptoms and cravings. The National Institute on Drug Abuse said much is still unknown about the long-term and short-term effects of kratom use.
What People Are Saying
Secretary of the Department of Health and Human Services Robert F. Kennedy, Jr., in a statement: "Today, we're taking action on 7-OH as a critical step in the fight against opioid addiction. We will protect the health of our nation's youth as we advance our mission to Make America Healthy Again."
FDA Commissioner Marty Makary, in a statement: "Vape stores are popping up in every neighborhood in America, and many are selling addictive products like concentrated 7-OH. After the last wave of the opioid epidemic, we cannot get caught flat-footed again. 7-OH is an opioid that can be more potent than morphine. We need regulation and public education to prevent another wave of the opioid epidemic."
What Happens Next
The Drug Enforcement Agency is reviewing the FDA's recommendation and will have final authority on the scheduling of the substance. Under the Controlled Substances Act, drugs are placed into one of five different schedules based on various factors, including medical use and potential for abuse.
Do you have a story that Newsweek should be covering? Do you have any questions about this story? Contact LiveNews@newsweek.com.
Update 7/29/25, 12:56 p.m. ET: This article was updated with additional information.
View 0 Comments
Submit Correction
View Editorial & AI Guidelines